Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 24Carcinoma, Renal Cell 11Kidney Neoplasms 8Neoplasm Metastasis 5Lung Neoplasms 5Colorectal Neoplasms 5Colonic Neoplasms 5Wilms Tumor 4Pancreatic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Urinary Bladder Neoplasms 3Testicular Neoplasms 3Rectal Neoplasms 3Breast Neoplasms 3Testicular Germ Cell Tumor 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Ovarian Neoplasms 2Multiple Myeloma 2Mesothelioma, Malignant 2Melanoma 2Liver Neoplasms 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Medullary 2

Interventions

pembrolizumab 7padeliporfin 5Nivolumab 4Everolimus 4Sunitinib 3Sorafenib 3Mitomycin 3fludarabine 2epothilone B 2durvalumab 2cabozantinib 2Ipilimumab 2Cyclophosphamide 2Cisplatin 21-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2volociximab 1vinflunine 1sipuleucel-T 1sargramostim 1pemigatinib 1palladium-bacteriopheophorbide 1palbociclib 1obinutuzumab 1luprolide acetate gel depot 1lenvatinib 1ixabepilone 1fludarabine phosphate 1enzalutamide 1belzutifan 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × sargramostim × Genitourinary × Clear all
NCT00176280 2015-06-18

Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma

University of Kentucky

Phase 2 Withdrawn
Genitourinary

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡